| Insider | Role | Shares | Value | Buys | Sells |
|---|
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Galbraith Kenneth
Chair & CEO
2 companies
Holdings by Company
Current Shares222.0K
Est. Value-
Net Activity-189,586
Bought: 0Sold: 189.6K
Current Shares15.0K
Est. Value-
Net Activity0
Bought: 0Sold: 0
Transaction History
Showing 6 transactions
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2026-01-12 | ZYME | Chair & CEO | Sale+OE | 30,424 | $22.67 | $689,818.56 | -11.8% | → |
| 2026-01-05 | ZYME | Chair & CEO | Sale+OE | 54,343 | $25.10 | $1,363,840.84 | -13.4% | → |
| 2025-12-22 | ZYME | Chair & CEO | Sale+OE | 47,528 | $27.02 | $1,284,311.12 | -26.3% | → |
| 2025-01-06 | ZYME | Chair & CEO | Sale+OE | 57,291 | $14.92 | $855,016.61 | -30.9% | → |